DELAFIELD, Wis. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high or takes out a prior overhead resistance point, then it's free to find new buyers and momentum players who can ultimately push the stock significantly higher.
One example of a successful breakout trade I flagged recently was wireless telecom player China Techfaith Wireless (CNTF), which I featured in Dec. 19's "5 Stocks Under $10 Set to Soar" at $1.50 share. I mentioned in that piece that shares of CNTF had been trending sideways over the last few months, with shares moving between $1.28 on the downside and $1.60 on the upside. Shares of CNTF were just starting to spike higher back above its 50-day moving average of $1.46 a share with strong upside volume. That move was quickly pushing shares of CNTF within range of triggering a big breakout trade above some near-term overhead resistance levels at $1.54 to $1.60 a share.
Guess what happened? Shares of CNTF didn't wait long to trigger that breakout, since the stock started to take out those key overhead resistance levels the following week. Shares of CNTF have continued to uptrend strong since clearing those breakout levels, and shares of CNTF have exploded higher today tagging an intraday high of $2.24 a share. That represents a monster gain of 50% in about a month for anyone who bought this stock once it broke out. As you can see, trading breakouts can lead to massive gains in very short timeframes.
10 Best Managed Healthcare Stocks For 2015: CEL-SCI Corp (CVM)
CEL-SCI Corporation (CEL-SCI), incorporated on March 22, 1983, is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Multikine
CEL-SCI's Multikine, is being developed for the treatment of cancer. It is a cancer immunotherapy drugs called Combination Immunotherapy because it combines active and passive immunity in one product. It is the only cancer immunotherapy that both kills cancer cells and activates the general immune system to destroy the cancer. Multikine target the tumor micro-metastases for treatment failure. Multikine is also applicable in many other solid tumors.
New Manufacturing Facility
CEL-SCI's facility manufactures Multikine for CEL-SCI's Phase III clinical trial. CEL-SCI offers the use of the facility as a service to pharmaceutical companies and others, particularly those that need to fill and finish their drugs in a cold environment. Fill and finish is the process of filling injectable drugs in a sterile manner.
LEAPS
CEL-SCI's patented T-cell Modulation Process uses heteroconjugates to direct the body to choose a specific immune response. The heteroconjugate technology, referred to as LEAPS, is intended to stimulate the human immune system to fight bacterial, viral and parasitic infections, as well as autoimmune, allergies, transplantation rejection and cancer. Administered like vaccines, LEAPS combines T-cell binding ligands with small, disease associated and peptide antigens.
Using the LEAPS technology, CEL-SCI has created a peptide treatment for H1N1 (swine flu) hospitalized patients. This LEAPS flu treatment is designed to focus on the conserved, non-changing epitopes of the di! fferent strains of Type A Influenza viruses, including swine, avian or bird, and Spanish Influenza. CEL-SCI's LEAPS flu treatment contains epitopes.
Advisors' Opinion:- [By Bryan Murphy]
To say that 2014 has been a good year so far for CEL-SCI Corporation (NYSEMKT:CVM) would be an understatement. It's been a great year for the company, and more specifically, its shareholders. CVM is up 96% year-to-date, cutting into a big chunk of the loss that was suffered in 2013. And, though a near-doubling in less than a month would normally be an invitation to a painful wave of profit-taking, in the case of CEL-SCI, the situation says this is one of those rallies that could get hotter the hotter it gets.
- [By Bryan Murphy]
Look out AbbVie Inc. (NYSE:ABBV), and Gilead Sciences, Inc. (NASDAQ:GILD), you may want to look over your shoulder as well. There's a new immunology player coming to town, and its name is CEL-SCI Corporation (NYSEMKT:CVM). Yes, AbbVie may be the name behind blockbuster drug Humira - with nearly $10 billion in sales in 2012 - while Gilead Sciences is saving HIV patients' lives with immunological therapies Stribild and Complera. But, small cap company CEL-SCI may be closer to launching its own immunology drug sooner than most investors realize.
- [By James E. Brumley]
When biotech-savvy investors think of immunology stocks, they tend to gravitate towards a name like Dendreon Corporation (NASDAQ:DNDN), which for all intents and purposes introduced the world's first cancer vaccine, Provenge, as a treatment for prostate cancer. Traders with a better-than-average knowledge of the immunology field may turn their attention to a company like CEL-SCI Corporation (NYSEMKT:CVM). CEL-SCI doesn't have a product on the market yet, but its head and neck cancer drug - which also uses immunology - is in Phase 3 testing right now, and looks very promising. There are other, and smaller, stocks within the world of immunology, however, that deserve a closer look from the market, and one of the most exciting ones further down the size scale is TNI Biotech Inc. (OTCMKTS:TNIB).
Top 5 Tech Stocks To Buy For 2014: VizStar Inc (VIZS)
VizStar, Inc. (VizStar), formerly Easy CD Yearbook, Inc., incorporated on June 27, 2006, is a development-stage company. The Company focuses to market software, which enables schools, clubs and organizations to produce their own multimedia yearbook. On June 11, 2010, Celestial Jets, Inc. (Celestial Jets) merged with the Company. Celestial Jets merged (the merger) with and into the Company�� wholly owned subsidiary, Celestial Acquisition Corp. Upon the merger, the name of Celestial Acquisition Corp. became Celestial Jets, Inc. In December 2012, the Company acquired Kimberly Parry Corporation.
A multimedia yearbook is a compact disc (CD)/ digital versatile disc (DVD), which contains video, photos, audio and text that is personal computer (PC) and Mac compatible. As of May 31, 2010, the Company had no revenues.
The Company competes with Yeardisk, Digital Journey LLC and Interactive Software Designs.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks VizStar Inc (OTCMKTS: VIZS), SOHM Inc (OTCMKTS: SHMN) and American Soil Technologies, Inc (OTCMKTS: SOYL) have been getting some attention in various investment newsletters with two out of three of these stocks being the subject of paid promotions. However, there is nothing wrong with some paid for attention so long as everything is properly disclosed, but its going to be up to investors and traders alike to ultimately decide whether any of these stocks have what it takes to be the next hot stock. With that in mind, here is a quick reality check about all three small cap stocks:
Top 5 Tech Stocks To Buy For 2014: Sigma Designs Inc.(SIGM)
Sigma Designs, Inc. provides integrated system-on-chip solutions (SoC) for the Internet protocol television (IPTV), media processor, connected home and media player, prosumer and industrial audio/video, high definition television, and PC-based add-in markets. The company offers semiconductors with a suite of real-time software that enables synchronous processing of video, audio, and graphics streams for various applications. Its media processor product line represents a family of SoC solutions that are a component of multiple consumer applications, which process digital video and audio content comprising IPTV, connected media players, and portable media players. The company?s home networking product line consists of wired networking solutions based on HomePNA, HomePlug AV, and G.hn standards, as well as wireless connectivity solutions based on Ultra-wideband technology. Its standards are used for transferring Internet protocol content across coaxial cables, phone lines, a nd power lines to enable service providers to deliver IPTV solutions and other media-rich applications. The company?s video image processor product line comprises of semiconductors that provide video output for professional and prosumer applications. Its home control and energy management automation product line includes wireless transceiver devices along with a mesh networking protocol. The company offers its home connectivity products under the CopperGate; wireless connectivity solutions under the CoAir; video image processors under the VXP; and wireless transceiver devices under the Z-Wave brands. It also provides software elements, such as multimedia library, security management software, and porting adaptations. In addition, the company offers PC-based solutions. It sells its products through direct sales force, manufacturer representatives, and independent distributors primarily in Asia, Europe, and North America. The company was founded in 1982 and is headquartered i n Milpitas, California.
Advisors' Opinion:- [By Roberto Pedone]
One technology player that insiders are loading up on here is Sigma Designs (SIGM), which provides integrated chipset solutions that serve as the foundation for consumer products including televisions, set-top boxes and video networking products. Insiders are buying this stock into decent weakness, since shares are down by 13.9% in the last three months.
Sigma Designs has a market cap of $165 million and an enterprise value of $98 million. This stock trades at a premium valuation, with a forward price-to-earnings of 29.88. Its estimated growth rate for this year is 114.2%, and for next year it's pegged at -5.9%. This is a cash-rich company, since the total cash position on its balance sheet is $61.74 million and its total debt is zero.
The CEO just bought 454,546 shares, or $2.5 million worth of stock, at $5.50 per share.
From a technical perspective, SIGM is currently trending below both its 50-day and 200-day moving averages, which is a bearish sign. This stock recently gapped down from $5.50 to below $4.40 a share with heavy downside volume. Following that move, shares of SIGM went on to hit a new low of $4.04 a share. That said, this stock has started to rebound off that $4.04 low and it's now moving within range of triggering a near-term breakout trade.
If you're bullish on SIGM, then I would look for long-biased trades as long as this stock is trending above some near-term support at $4.48 or above its recent low of $4.04, and then once breaks out above some near-term overhead resistance at $4.85 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 299,402 shares. If that breakout hits soon, then SIGM will set up to re-fill some of its previous gap down zone that started at $5.500 a share. This stock could even tag $5.75 to $6.20 a share if that gap gets filled with strong upside volume flows.
- [By Rebecca McClay]
In earnings news today, a few companies are reporting after the closing bell, including H & R Block Inc. (NYSE: HRB), which is up about 1%. Pike Electric Corp. (NYES: PIKE), Guidewire Software Inc. (NYSE: GWRE), and Sigma Designs Inc. (Nasdaq: SIGM) are also reporting quarterly earnings late this afternoon.
Top 5 Tech Stocks To Buy For 2014: China Sunergy Co. Ltd.(CSUN)
China Sunergy Co., Ltd. designs, develops, manufactures, and sells solar cells and solar modules. It offers monocrystalline and multicrystalline silicon solar cells; and standard P-type solar cells and HP solar cells, as well as emitter cells. The company sells its products to module manufacturers, system integrators, and distributors. It sells solar cells and modules under CSUN and CEEG brand names primarily in Europe, the People?s Republic of China, India, South Korea, Australia, and the Untied States. The company was founded in 2004 and is headquartered in Nanjing, the People?s Republic of China.
Advisors' Opinion:- [By Eric Volkman]
China Sunergy (NASDAQ: CSUN ) results for the company's fiscal Q4 and 2012 have been released. For the quarter, total sales were $54.4 million, less than half the $110.8 million the firm posted in the same period the previous year. Net loss, meanwhile, was steeper at $70.5 million ($5.27 per diluted American Depositary Share), compared to Q4 2011's red figure of $49.6 million ($3.71).
No comments:
Post a Comment